Skip to main content
NXGL
NASDAQ Industrial Applications And Services

Shareholders to Vote on Massive Dilution, Reverse Split, and Nevada Reincorporation

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$0.582
Mkt Cap
$6.82M
52W Low
$0.481
52W High
$2.89
52W Position info
21% above low
Off High info
80% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

NXGL sits 21% above its 52-week low of $0.481 on light trading volume (0.1× avg).

Summary

NEXGEL shareholders will vote on proposals for massive potential dilution from recent financings, a significant increase in authorized shares, a reverse stock split to avoid delisting, and reincorporation to Nevada.


Key Events · Corporate Governance and Compliance · NXGL

  • Massive Potential Dilution from Financings

    Shareholders are asked to approve the issuance of over 31.9 million shares from April and May 2026 convertible notes and warrants. This represents approximately 77.6% dilution of current outstanding shares at initial conversion prices, with terms including no floor on conversion price and full-ratchet anti-dilution, leading to potentially unlimited dilution.

  • Significant Insider Participation in Financings

    Key insiders, including CEO Adam Levy, Director Scott R. Henry, and newly appointed Director Brian J. Kieser (and his affiliated entity Sequence LifeScience, Inc.), participated in the dilutive April and May 2026 financings.

  • Proposed Increase in Authorized Shares

    The company seeks to increase authorized common stock from 25 million to 100 million shares. This is necessary to cover an existing shortfall of over 22 million shares required for outstanding convertible securities and future capital needs, and to provide flexibility for future capital raises.

  • Discretionary Reverse Stock Split

    To regain compliance with Nasdaq's minimum $1.00 bid price requirement and avoid delisting, the board seeks authority to implement a reverse stock split at a ratio between 1-for-2 and 1-for-10.


Analysis · NXGL · Industrial Applications And Services

NEXGEL is seeking shareholder approval for several critical proposals at its upcoming Annual Meeting, including a highly dilutive issuance of shares from recent convertible note and warrant financings, a substantial increase in authorized common stock, and a discretionary reverse stock split to maintain Nasdaq listing. The company also proposes reincorporating to Nevada, which would bundle the authorized share increase and reverse split authority under new, potentially more management-friendly, corporate governance rules. These measures are crucial for the company's financial stability and continued listing, especially given its recent "going concern" warning and Nasdaq deficiency notice.

How filings like this one have moved

In the 30 days to Oct 3, 2026, 40.9% of the 320 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.38%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, NXGL was trading at $0.58 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $6.8M. The 52-week trading range was $0.48 to $2.89. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

NXGL - Latest Insights

NXGL
Sep 24, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.262
Real-time Price: $0.1679 info
Change: -$0.0941 (-36%) info
Market Cap: $2.146M info
NXGL
Sep 23, 2026, 5:20 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.270
Real-time Price: $0.1679 info
Change: -$0.1021 (-38%) info
Market Cap: $2.146M info
NXGL
Aug 24, 2026, 5:14 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $0.368
Real-time Price: $0.1679 info
Change: -$0.2001 (-54%) info
Market Cap: $2.146M info
NXGL
Aug 20, 2026, 4:05 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $0.3874
Real-time Price: $0.1679 info
Change: -$0.2195 (-57%) info
Market Cap: $2.146M info
NXGL
Aug 20, 2026, 12:39 PM EDT
Filing Type: S-1
Importance Score:
8
Price at Filing: $0.3798
Real-time Price: $0.1679 info
Change: -$0.2119 (-56%) info
Market Cap: $2.146M info